DR. REDDY LABORATORY LIMITED

Dr. Reddy's Laboratories is a leading pharmaceutical company founded by Dr. Kallam Anji Reddy in 1984. Here's a brief overview ¹ ²:

- *Business*: Dr. Reddy's develops, manufactures, and markets a wide range of pharmaceuticals, including generics, over-the-counter drugs, and biologics.

- *Global Presence*: The company operates in over 70 countries, with a significant presence in India, the US, and Europe.

- *Product Portfolio*: Dr. Reddy's offers a diverse portfolio of products, including gastrointestinal, cardiovascular, pain management, oncology, and dermatology medications.

- *Research and Development*: The company invests heavily in R&D, focusing on innovation and affordability.

- *Leadership*: G.V. Prasad serves as Co-Chairman and Managing Director, while Erez Israeli is the CEO.

Some key financial highlights include ³ ⁴:

- *Market Capitalization*: ₹1,02,725 Cr (approximately $1.05 trillion)

- *Revenue*: ₹32,643.90 Cr (FY2025)

- *Net Profit*: ₹5,703.50 Cr (FY2025)

- *Stock Price*: ₹1,284.30 (as of October 27, 2025)

Dr. Reddy's has received notable updates, including a recent inspection by the USFDA, which resulted in a Voluntary Action Indicated (VAI) status for its Andhra facility ⁵.